reference/33554931

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33554931

Outgoing Links

Predicate	Object
contentType	Case Reports\|Letter
endingPage	1073
issn	0278-5846
issueIdentifier	4
pageRange	1072-1073
publicationName	Progress in Neuro-Psychopharmacology and Biological Psychiatry
startingPage	1072
bibliographicCitation	Iyo M, Shirayama Y, Watanabe H, Fujisaki M, Miyatake R, Fukami G, Shiina A, Nakazato M, Shiraishi T, Ookami T, Hashimoto K. Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2008 May;32(4):1072–3. doi: 10.1016/j.pnpbp.2008.01.005.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9a59b98d45d6a71b3758c3019d4de45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4287c2bcd1817ba12f4a4f729c5f23c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aef034ba125b6b02b85f5b8afab48783 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d89c80aff6cd4f9825cac73049d5e375 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed29232ebe6eb195e95c8b894e60e062 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a750b00ca4d24e87ee0b3b2c2ded0175 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1827027ecde477702a2b4942cb34b8f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2be45bc48c223f9c4bceab6150f35507 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfd709ec255431d639c99993072d2073 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_628074f3ecfac386ea61b59f160b7362 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b65352054a1e8f780205c78c3aba77b
date	2008-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/18262707 https://doi.org/10.1016/j.pnpbp.2008.01.005
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6714 https://portal.issn.org/resource/ISSN/0278-5846 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6752
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia
discusses	http://id.nlm.nih.gov/mesh/M0026516 http://id.nlm.nih.gov/mesh/M0026372 http://id.nlm.nih.gov/mesh/M0025397
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003072Q000188 http://id.nlm.nih.gov/mesh/D017367Q000627 http://id.nlm.nih.gov/mesh/D003072Q000209 http://id.nlm.nih.gov/mesh/D017480Q000819 http://id.nlm.nih.gov/mesh/D016666Q000627 http://id.nlm.nih.gov/mesh/D012565
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000097605 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11385 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5324346

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127634583

Total number of triples: 47.